Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 180-182, 2007
Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 178-179
Centers for Disease Control and Prevention, Emerging Infectious Diseases, 1(13), p. 179-180
Full text: Download
sis of discharge data to compare find- ings from the United States with data from Germany. We therefore deter- mined the absolute number of inpa- tient discharges from all hospitals in Germany with the number of dis- charge diagnoses of CDAD reported in the national Statistische Bundesamt for the years 2000-2004. We then cal- culated the incidence of CDAD as a discharge diagnosis for each year and stratified our results by age groups (Figure). Our results confirm the observa- tions from the United States. The effect of C. difficile on illness of patients in hospitals in Germany has escalated dramatically. This is true especially for patients >60 years of age. This trend indicates the need for increased awareness of this pathogen and a concerted effort to control CDAD by reducing unnecessary antimicrobial drug use and imple- menting currently recommended infection control measures. It also highlights the need to develop more rapid and accurate diagnostic tools and more effective prevention and treatment strategies.